| Foundational challenges in assuring alignment and safety of large language models U Anwar, A Saparov, J Rando, D Paleka, M Turpin, P Hase, ES Lubana, ... arXiv preprint arXiv:2404.09932, 2024 | 38 | 2024 |
| What Affects Perceived Trustworthiness of Online Medical Information and Subsequent Treatment Decision Making? Randomized Trials on the Role of Uncertainty and Institutional Cues G Recchia, KS Moser, ALJ Freeman MDM Policy & Practice 9 (1), 23814683241226660, 2024 | | 2024 |
| Do colored cells in risk matrices affect decision‐making and risk perception? Insights from randomized controlled studies R Proto, G Recchia, S Dryhurst, ALJ Freeman Risk analysis 43 (10), 2114-2128, 2023 | 4 | 2023 |
| Inverse scaling: When bigger isn't better IR McKenzie, A Lyzhov, M Pieler, A Parrish, A Mueller, A Prabhu, ... arXiv preprint arXiv:2306.09479, 2023 | 64* | 2023 |
| Investigating the presentation of uncertainty in an icon array: A randomized trial G Recchia, ACE Lawrence, ALJ Freeman PEC innovation 1, 100003, 2022 | 11 | 2022 |
| Risk perceptions of COVID-19 around the world S Dryhurst, CR Schneider, J Kerr, ALJ Freeman, G Recchia, ... COVID-19, 162-174, 2022 | 2026 | 2022 |
| Making BRCA1 genetic test reports easier to understand through user-centered design: A randomized trial G Recchia, ACE Lawrence, L Capacchione, ALJ Freeman Genetics in Medicine 24 (8), 1684-1696, 2022 | 2 | 2022 |
| How people understand risk matrices, and how matrix design can improve their use: Findings from randomized controlled studies H Sutherland, G Recchia, S Dryhurst, ALJ Freeman Risk Analysis 42 (5), 1023-1041, 2022 | 17 | 2022 |
| Risk Matrix Comprehension (Study 4) R Protopopescu, ALJ Freeman, G Recchia, S Dryhurst OSF, 2021 | | 2021 |
| Clinical impact of the predict prostate risk communication tool in men newly diagnosed with nonmetastatic prostate cancer: A multicentre randomised controlled trial D Thurtle, V Jenkins, A Freeman, M Pearson, G Recchia, P Tamer, ... European Urology 80 (5), 661-669, 2021 | 15 | 2021 |
| Teaching autoregressive language models complex tasks by demonstration G Recchia arXiv preprint arXiv:2109.02102, 2021 | 19 | 2021 |
| Correlates of intended COVID-19 vaccine acceptance across time and countries: results from a series of cross-sectional surveys JR Kerr, CR Schneider, G Recchia, S Dryhurst, U Sahlin, C Dufouil, ... BMJ open 11 (8), e048025, 2021 | 102 | 2021 |
| The effects of cues about source and quality of algorithmically-sourced information on trust and decision-making processes: Main study G Recchia, K Moser, ALJ Freeman, AM van der Bles OSF, 2021 | | 2021 |
| How well did experts and laypeople forecast the size of the COVID-19 pandemic? G Recchia, ALJ Freeman, D Spiegelhalter PloS one 16 (5), e0250935, 2021 | 36 | 2021 |
| How do the UK public interpret COVID-19 test results? Comparing the impact of official information about results and reliability used in the UK, USA and New Zealand: a … G Recchia, CR Schneider, ALJ Freeman BMJ open 11 (5), e047731, 2021 | 1 | 2021 |
| COVID-19 risk perception: a longitudinal analysis of its predictors and associations with health protective behaviours in the United Kingdom CR Schneider, S Dryhurst, J Kerr, ALJ Freeman, G Recchia, ... Journal of Risk Research 24 (3-4), 294-313, 2021 | 213 | 2021 |
| Communicating personalized risks from COVID-19: guidelines from an empirical study ALJ Freeman, J Kerr, G Recchia, CR Schneider, ACE Lawrence, ... Royal Society open science 8 (4), 201721, 2021 | 27 | 2021 |
| Predictors of COVID-19 vaccine acceptance across time and countries JR Kerr, CR Schneider, G Recchia, S Dryhurst, U Sahlin, C Dufouil, ... MedRxiv, 2020.12. 09.20246439, 2020 | 35 | 2020 |
| How do the public interpret COVID-19 swab test results? comparing the impact of official information about results and reliability used in the UK, US and New Zealand: a … G Recchia, CR Schneider, ALJ Freeman MedRxiv, 2020.12. 04.20243840, 2020 | 2 | 2020 |
| Communicating risks and benefits to cardiology patients G Recchia, A Freeman Heart 106 (23), 1862-1863, 2020 | 2 | 2020 |
George KachergisResearch Scientist, Stanford UniversityVerified email at stanford.edu